- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- abnormal skin condition / IMPC
- decreased circulating alanine transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- thrombocytosis / IMPC
- decreased circulating aspartate transaminase level / IMPC
- preweaning lethality, complete penetrance / IMPC
- hyperplasia / IMPC
- lipid deposition / IMPC
- extramedullary hemopoiesis / IMPC
C57BL/6NTac-Sar1btm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:05863 |
International strain name | C57BL/6NTac-Sar1btm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0113_3_C11 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Sar1btm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Sar1b |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0113_3_C11. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac |
Breeding at archiving centre | Frozen material received. |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Chylomicron retention disease / Orphanet_71
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- hyperplasia / IMPC
- decreased circulating aspartate transaminase level / IMPC
- lipid deposition / IMPC
- thrombocytosis / IMPC
- extramedullary hemopoiesis / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal skin condition / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating alanine transaminase level / IMPC
- decreased circulating LDL cholesterol level / IMPC
- preweaning lethality, complete penetrance / IMPC
MGI phenotypes (allele matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal skin condition / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- increased mean corpuscular hemoglobin / MGI
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal skin condition / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- increased mean corpuscular hemoglobin / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).